The first version of the Standard PREanalytical Code (SPREC) was developed in 2009 by the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group to facilitate documentation and communication of the most important preanalytical quality parameters of different types of biospecimens used for research. This same Working Group has now updated the SPREC to version 2.0, presented here, so that it contains more options to allow for recent technological developments. Existing elements have been fine tuned. An interface to the Biospecimen Reporting for Improved Study Quality (BRISQ) has been defined, and informatics solutions for SPREC implementation have been developed. A glossary with SPREC-rel...
Recently, CEN/TS 17626:2021, the European pre-analytical standard for human specimens intended for m...
Biospecimens acquired during routine medical practice are the primary sources of molecular informati...
AbstractThe lack of readily available biomarkers is a significant hindrance toward progressing to ef...
The first version of the Standard PREanalytical Code (SPREC) was developed in 2009 by the Internatio...
The first version of the Standard PREanalytical Code (SPREC) was developed in 2009 by the Internatio...
Background: Management and traceability of biospecimen preanalytical variations are necessary to pro...
Biobanks provide stored material to basic, translational, and epidemiological research and this mate...
Biobanks provide stored material to basic, translational, and epidemiological research and this mate...
Human biospecimens are subjected to collection, processing, and storage that can significantly alter...
Human biospecimens are subjected to collection, processing, and storage that can significantly alter...
The suitability of samples for a given research depends on many variables, among which, the best pre...
Human biospecimens are subjected to collection, processing, and storage that can significantly alter...
The standardized preanalytical code (SPREC) aggregates warm ischemia (WIT), cold ischemia (CIT), and...
The lack of readily available biomarkers is a significant hindrance toward progressing to effective ...
The lack of readily available biomarkers is a significant hindrance toward progressing to effective ...
Recently, CEN/TS 17626:2021, the European pre-analytical standard for human specimens intended for m...
Biospecimens acquired during routine medical practice are the primary sources of molecular informati...
AbstractThe lack of readily available biomarkers is a significant hindrance toward progressing to ef...
The first version of the Standard PREanalytical Code (SPREC) was developed in 2009 by the Internatio...
The first version of the Standard PREanalytical Code (SPREC) was developed in 2009 by the Internatio...
Background: Management and traceability of biospecimen preanalytical variations are necessary to pro...
Biobanks provide stored material to basic, translational, and epidemiological research and this mate...
Biobanks provide stored material to basic, translational, and epidemiological research and this mate...
Human biospecimens are subjected to collection, processing, and storage that can significantly alter...
Human biospecimens are subjected to collection, processing, and storage that can significantly alter...
The suitability of samples for a given research depends on many variables, among which, the best pre...
Human biospecimens are subjected to collection, processing, and storage that can significantly alter...
The standardized preanalytical code (SPREC) aggregates warm ischemia (WIT), cold ischemia (CIT), and...
The lack of readily available biomarkers is a significant hindrance toward progressing to effective ...
The lack of readily available biomarkers is a significant hindrance toward progressing to effective ...
Recently, CEN/TS 17626:2021, the European pre-analytical standard for human specimens intended for m...
Biospecimens acquired during routine medical practice are the primary sources of molecular informati...
AbstractThe lack of readily available biomarkers is a significant hindrance toward progressing to ef...